Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Lin

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Antibiotics|December 1, 1995
Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin ID J Detlefsen, S E Hill, K J Volk, et al.
Blood|April 1, 1991
Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cellsK Kelleher, K Bean, S C Clark, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationC A Deminie, C M Bechtold, D Stock, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsR E Rose, Y F Gong, J A Greytok, et al.
Antiviral Research|October 1, 1993
Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsM Alam, C M Bechtold, A K Patick, et al.
Journal of Virology|April 1, 1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorA K Patick, R Rose, J Greytok, et al.
Journal of Medicinal Chemistry|June 10, 1994
Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SARJ C Barrish, E Gordon, M Alam, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitorP F Lin, H Samanta, C M Bechtold, et al.
The Journal of Infectious Diseases|November 1, 1994
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapyP F Lin, H Samanta, R E Rose, et al.
Genetics and Molecular Research : GMR|January 20, 2016
Silencing effect of lentiviral vectors encod-ing shRNA of Herp on endoplasmic reticulum stress and inflammatory responses in RAW 264.7 macrophagesF L Chen, Q Li, J Y Zhang, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Antibiotics|December 1, 1995
Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin ID J Detlefsen, S E Hill, K J Volk, et al.
Blood|April 1, 1991
Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cellsK Kelleher, K Bean, S C Clark, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationC A Deminie, C M Bechtold, D Stock, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsR E Rose, Y F Gong, J A Greytok, et al.
Antiviral Research|October 1, 1993
Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsM Alam, C M Bechtold, A K Patick, et al.
Journal of Virology|April 1, 1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorA K Patick, R Rose, J Greytok, et al.
Journal of Medicinal Chemistry|June 10, 1994
Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SARJ C Barrish, E Gordon, M Alam, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitorP F Lin, H Samanta, C M Bechtold, et al.
The Journal of Infectious Diseases|November 1, 1994
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapyP F Lin, H Samanta, R E Rose, et al.
Genetics and Molecular Research : GMR|January 20, 2016
Silencing effect of lentiviral vectors encod-ing shRNA of Herp on endoplasmic reticulum stress and inflammatory responses in RAW 264.7 macrophagesF L Chen, Q Li, J Y Zhang, et al.
Pageof 6